Dipexium Pharmaceuticals

Dipexium Pharmaceuticals offers small peptide antibiotics to treat certain mild and moderate skin infections in superficial wounds.

Dipexium Pharmaceuticals, LLC operates as a biopharmaceutical company that develops and commercializes, pexiganan, a small peptide anti-infective agent. It provides Locilex, a small peptide topical antibiotic for the treatment of mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus. The company was founded in 2010 and is based in White Plains, New York.